Core Viewpoint - Guangji Pharmaceutical announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received the approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material Vitamin B6 [1] Group 1 - The approval includes a notification for the chemical raw material Vitamin B6, which is used in the production of Vitamin B6 tablets and injections [1]

Core Viewpoint - Guangji Pharmaceutical (000952) announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received the approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material Vitamin B6 [1] Group 1 - The approved raw material is intended for the production of Vitamin B6 tablets and Vitamin B6 injection [1]

Group 1 - Dongli Machinery participated in the 2025 China Automobile Off-Road Rally Championship and won the T2.3 group championship as a club team [1] - The Arnoda-Black Bear Tire Chery Racing Team secured the T1.1 group championship [1] - Great Wall Haval Team, using Dongli Machinery's "Taihang Water" brand shock absorbers, won championships in the T2.1 and T2.E groups with a total of five vehicles [1] Group 2 - Guangji Pharmaceutical's subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., received approval from the Hubei Provincial Drug Administration for the re-registration of the chemical raw material drug Vitamin B6 [1] - The raw material is intended for the production of Vitamin B6 tablets and Vitamin B6 injection solutions [1]

Group 1 - The core point of the article is that Guangji Pharmaceutical's subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., has received approval for the re-registration of its chemical raw material Vitamin B6 from the Hubei Provincial Drug Administration, ensuring the stability and continuity of its production and sales qualifications [1] Group 2 - Vitamin B6 is used as a raw material for the production of Vitamin B6 tablets and injections, indicating its importance in the pharmaceutical industry [1] - The approval of the re-registration certificate is crucial for maintaining the company's operational capabilities in the Vitamin B6 market [1]

Group 1 - The core point of the article is that Guangji Pharmaceutical (000952.SZ) announced that its subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd., received the approval notice for the re-registration of the chemical raw material Vitamin B6 from the Hubei Provincial Drug Administration [1] - The approval ensures the stability and continuity of the production and sales qualifications for Vitamin B6, which is used in the production of Vitamin B6 tablets and injections [1]